Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elastic NV (ESTC) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance

Elastic NVTrade
Vertex Pharmaceuticals IncorporatedTrade

Price performance (Past 24H)

Key statistics

Elastic NV vs Vertex Pharmaceuticals Incorporated — how do they compare? Elastic NV trades at $75.22 (market cap $7.94B), while Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 16.9× Elastic NV's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Elastic NV nearer its low. Which is the better fit depends on your goals.

ESTCVRTX
Market Cap
$7.94B$134.25B
Sector
TechnologyHealth
52-Week High
$94.47$529.65
52-Week Low
$43.30$376.62
Enterprise Value
$7.16B$128.37B

Returns comparison

Trailing returns across standard periods

About Elastic NV

Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.

Read more on ESTC

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX